Physician profile
Kyle Christopher Lambert
NPI 1184491581
$557.57
in general payments reported to CMS, 2019-2025
13 companies · $75.13 in 2025
The $75.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $482 · 2025: $75.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $182.51 | 2024 | Prospera |
| Lilly USA, LLC | $107.58 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $52.86 | 2024 | Ozempic, Rybelsus, Wegovy |
| Daiichi Sankyo INC. | $52.23 | 2024-2025 | Injectafer |
| Sanofi-Aventis U.S. LLC | $33.02 | 2024 | |
| Amgen INC. | $21.49 | 2024 | Evenity |
| Eisai INC. | $18.92 | 2024 | |
| Astellas Pharma US INC | $16.06 | 2025 | Veozah |
| Phadia US INC. | $15.45 | 2024 | Immunocap |
| Echosens North America, INC. | $14.91 | 2025 | Fibroscan |
| Lexicon Pharmaceuticals, INC. | $14.84 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.17 | 2024 | Jardiance |
| Edwards Lifesciences Corporation | $13.53 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.